@article{bansilal_efficacy_2015-1,
	title = {Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: {The} {Rivaroxaban} {Once}-daily, {Oral}, {Direct} {Factor} {Xa} {Inhibition} {Compared} with {Vitamin} {K} {Antagonism} for {Prevention} of {Stroke} and {Embolism} {Trial} in {Atrial} {Fibrillation} ({ROCKET} {AF} {Trial})},
	volume = {170},
	issn = {00028703},
	shorttitle = {Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0002870315004433},
	doi = {10.1016/j.ahj.2015.07.006},
	language = {en},
	number = {4},
	urldate = {2019-05-01},
	journal = {American Heart Journal},
	author = {Bansilal, Sameer and Bloomgarden, Zachary and Halperin, Jonathan L. and Hellkamp, Anne S. and Lokhnygina, Yuliya and Patel, Manesh R. and Becker, Richard C. and Breithardt, Günter and Hacke, Werner and Hankey, Graeme J. and Nessel, Christopher C. and Singer, Daniel E. and Berkowitz, Scott D. and Piccini, Jonathan P. and Mahaffey, Kenneth W. and Fox, Keith A.A.},
	month = oct,
	year = {2015},
	pages = {675--682.e8},
	file = {Bansilal et al. - 2015 - Efficacy and safety of rivaroxaban in patients wit.pdf:/Users/neil.hawkins/Zotero/storage/WEHZVPCD/Bansilal et al. - 2015 - Efficacy and safety of rivaroxaban in patients wit.pdf:application/pdf},
}

{"_id":"MzzhBWLDQFrq2G4i6","bibbaseid":"bansilal-bloomgarden-halperin-hellkamp-lokhnygina-patel-becker-breithardt-etal-efficacyandsafetyofrivaroxabaninpatientswithdiabetesandnonvalvularatrialfibrillationtherivaroxabanoncedailyoraldirectfactorxainhibitioncomparedwithvitaminkantagonismforpreventionofstrokeandembolismtrialinatrialfibrillationrocketaftrial-2015","author_short":["Bansilal, S.","Bloomgarden, Z.","Halperin, J. L.","Hellkamp, A. S.","Lokhnygina, Y.","Patel, M. R.","Becker, R. C.","Breithardt, G.","Hacke, W.","Hankey, G. J.","Nessel, C. C.","Singer, D. E.","Berkowitz, S. D.","Piccini, J. P.","Mahaffey, K. W.","Fox, K. A."],"bibdata":{"bibtype":"article","type":"article","title":"Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)","volume":"170","issn":"00028703","shorttitle":"Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation","url":"https://linkinghub.elsevier.com/retrieve/pii/S0002870315004433","doi":"10.1016/j.ahj.2015.07.006","language":"en","number":"4","urldate":"2019-05-01","journal":"American Heart Journal","author":[{"propositions":[],"lastnames":["Bansilal"],"firstnames":["Sameer"],"suffixes":[]},{"propositions":[],"lastnames":["Bloomgarden"],"firstnames":["Zachary"],"suffixes":[]},{"propositions":[],"lastnames":["Halperin"],"firstnames":["Jonathan","L."],"suffixes":[]},{"propositions":[],"lastnames":["Hellkamp"],"firstnames":["Anne","S."],"suffixes":[]},{"propositions":[],"lastnames":["Lokhnygina"],"firstnames":["Yuliya"],"suffixes":[]},{"propositions":[],"lastnames":["Patel"],"firstnames":["Manesh","R."],"suffixes":[]},{"propositions":[],"lastnames":["Becker"],"firstnames":["Richard","C."],"suffixes":[]},{"propositions":[],"lastnames":["Breithardt"],"firstnames":["Günter"],"suffixes":[]},{"propositions":[],"lastnames":["Hacke"],"firstnames":["Werner"],"suffixes":[]},{"propositions":[],"lastnames":["Hankey"],"firstnames":["Graeme","J."],"suffixes":[]},{"propositions":[],"lastnames":["Nessel"],"firstnames":["Christopher","C."],"suffixes":[]},{"propositions":[],"lastnames":["Singer"],"firstnames":["Daniel","E."],"suffixes":[]},{"propositions":[],"lastnames":["Berkowitz"],"firstnames":["Scott","D."],"suffixes":[]},{"propositions":[],"lastnames":["Piccini"],"firstnames":["Jonathan","P."],"suffixes":[]},{"propositions":[],"lastnames":["Mahaffey"],"firstnames":["Kenneth","W."],"suffixes":[]},{"propositions":[],"lastnames":["Fox"],"firstnames":["Keith","A.A."],"suffixes":[]}],"month":"October","year":"2015","pages":"675–682.e8","file":"Bansilal et al. - 2015 - Efficacy and safety of rivaroxaban in patients wit.pdf:/Users/neil.hawkins/Zotero/storage/WEHZVPCD/Bansilal et al. - 2015 - Efficacy and safety of rivaroxaban in patients wit.pdf:application/pdf","bibtex":"@article{bansilal_efficacy_2015-1,\n\ttitle = {Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: {The} {Rivaroxaban} {Once}-daily, {Oral}, {Direct} {Factor} {Xa} {Inhibition} {Compared} with {Vitamin} {K} {Antagonism} for {Prevention} of {Stroke} and {Embolism} {Trial} in {Atrial} {Fibrillation} ({ROCKET} {AF} {Trial})},\n\tvolume = {170},\n\tissn = {00028703},\n\tshorttitle = {Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation},\n\turl = {https://linkinghub.elsevier.com/retrieve/pii/S0002870315004433},\n\tdoi = {10.1016/j.ahj.2015.07.006},\n\tlanguage = {en},\n\tnumber = {4},\n\turldate = {2019-05-01},\n\tjournal = {American Heart Journal},\n\tauthor = {Bansilal, Sameer and Bloomgarden, Zachary and Halperin, Jonathan L. and Hellkamp, Anne S. and Lokhnygina, Yuliya and Patel, Manesh R. and Becker, Richard C. and Breithardt, Günter and Hacke, Werner and Hankey, Graeme J. and Nessel, Christopher C. and Singer, Daniel E. and Berkowitz, Scott D. and Piccini, Jonathan P. and Mahaffey, Kenneth W. and Fox, Keith A.A.},\n\tmonth = oct,\n\tyear = {2015},\n\tpages = {675--682.e8},\n\tfile = {Bansilal et al. - 2015 - Efficacy and safety of rivaroxaban in patients wit.pdf:/Users/neil.hawkins/Zotero/storage/WEHZVPCD/Bansilal et al. - 2015 - Efficacy and safety of rivaroxaban in patients wit.pdf:application/pdf},\n}\n\n","author_short":["Bansilal, S.","Bloomgarden, Z.","Halperin, J. L.","Hellkamp, A. S.","Lokhnygina, Y.","Patel, M. R.","Becker, R. C.","Breithardt, G.","Hacke, W.","Hankey, G. J.","Nessel, C. C.","Singer, D. E.","Berkowitz, S. D.","Piccini, J. P.","Mahaffey, K. W.","Fox, K. A."],"bibbaseid":"bansilal-bloomgarden-halperin-hellkamp-lokhnygina-patel-becker-breithardt-etal-efficacyandsafetyofrivaroxabaninpatientswithdiabetesandnonvalvularatrialfibrillationtherivaroxabanoncedailyoraldirectfactorxainhibitioncomparedwithvitaminkantagonismforpreventionofstrokeandembolismtrialinatrialfibrillationrocketaftrial-2015","role":"author","urls":{"Paper":"https://linkinghub.elsevier.com/retrieve/pii/S0002870315004433"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","dataSources":["ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","v8uQmZsBpiqycmskv"],"keywords":[],"search_terms":["efficacy","safety","rivaroxaban","patients","diabetes","nonvalvular","atrial","fibrillation","rivaroxaban","once","daily","oral","direct","factor","inhibition","compared","vitamin","antagonism","prevention","stroke","embolism","trial","atrial","fibrillation","rocket","trial","bansilal","bloomgarden","halperin","hellkamp","lokhnygina","patel","becker","breithardt","hacke","hankey","nessel","singer","berkowitz","piccini","mahaffey","fox"],"title":"Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)","year":2015}